Dante Labs Announces Expansion of its Finance Team with the

CAMBRIDGE, United Kingdom, Sept. 14, 2021 (World NEWSWIRE) — Dante Labs, a world-wide leader in genomics and precision medicine, currently introduced the appointments of Andre Nel, Dalila Rahmani, Laura D’Angelo and Omar Elbakshish to the company’s management staff, expanding its world management to assistance scale the rising small business.

“We are thrilled to welcome Andre, Dalila, Laura and Omar to the expanding management group below at Dante,” explained Andrea Riposati, CEO of Dante Labs. “As we work to supply a extra human technique to healthcare, it is our shared vision of the long run and increasing relevance genomics is taking part in in health care that will aid to fulfill the unmet desires of our prospects from entire genome sequencing to drug discovery and advancement to COVID tests.”

These leaders will sign up for Dante’s finance workforce to enable scale the small business as we operate to deliver a international brand of assessments and providers ensuing in far better results for people all over the planet.

Major the team, Andre Nel joins Dante Labs as Chief Financial Officer. Andre delivers a lot more than 20 years of practical experience furnishing high-worth strategic and operational economic aid for world multibillion-dollar organizations these as Pfizer and Illumina. Most not long ago, Andre was the Vice President of Finance at Illumina (NASDAQ: ILMN) in San Diego.

Dalila joins Dante Labs as the Chief Accounting Officer. Dalila previously worked with Andre at Illumina as the head of Controllership and Shared Services for the EMEA location. Dalila has most a short while ago led the Illumina Professional Finance group, specializing in monetary forecasting, budgeting, enterprise partnering and administration. Prior to joining Illumina she started her profession as an auditor with Ernst & Younger. Dalila has a demonstrated historical past doing the job in the biotechnology market and a master’s diploma concentrated on Accounting and Finance. Her perform in the industry will advantage us tremendously in our extra personalized approach to medication and health care.

Laura D’Angelo joins Dante Labs as Vice President of Trader Relations. Most just lately, Laura was the Head of Investor Relations at Invitae (NYSE: NVTA), specializing in exterior communication targeting analysts, traders and fiscal media as well as clinician and affected individual buyers. With a vocation rooted in communications, Laura delivers a one of a kind perspective to Dante’s finance workforce as we transform sequencing details into life-saving solutions for the people today we serve.

Omar Elbakshish joins Dante Labs as Senior Director of Enterprise Finance. Experienced in monetary modeling, forecasting and small business partnering, Omar also joins Dante from Illumina. With a shown background doing work in finance roles in the biotechnology industry all through his career, Omar will assist Dante to deploy genomic applications that have actual effects on people’s life.

“I’m so happy to be top this passionate and talented finance team below at Dante Labs to help accelerate genomics on a global scale to make improvements to health care outcomes,” claimed Andre Nel, Chief Money Officer of Dante Labs. “Having worked formerly with Dalila and Omar and now collaborating with Laura, I’m self-confident we have the ideal team of experts to obtain our mission and reveal how essential genomics is to a holistic and human solution to health care about the globe.”

About Dante Labs
Dante Labs is a global genomic details enterprise setting up and commercializing a new course of transformative well being and longevity programs based mostly on whole genome sequencing and AI. Our property include things like a single of the greatest non-public genome databases with investigate consent, a proprietary software program platform intended to unleash the electric power of genomic knowledge at scale and proprietary procedures which allow an industrial method to genomic sequencing.

Headquartered in Cambridge, United Kingdom, with a analysis laboratory in Wolverhampton, Dante Labs supported the United kingdom Government’s urgent need to scale-up a high-potential, extremely automated tests alternative for Covid-19, such as contaminated patients as properly as people with antibodies. Dante Labs was in a position to supply by leveraging current technological innovation that had been created for entire genome sequencing.

Get hold of
Giorgio Lodi
[email protected]
+39 0862 191 0671
www.dantelabs.com